Show
Sort by
-
- Conference Paper
- C3
- open access
Efficacy of efgartigimod in generalized myasthenia gravis : myasthenia gravis composite score analysis from ADAPT
(2022) JOURNAL OF NEUROMUSCULAR DISEASES. In Journal of Neuromuscular Diseases 9(supplement 1). p.S82-S83 -
- Journal Article
- A1
- open access
Efficacy and safety of rozanolixizumab in moderate to severe generalized myasthenia gravis : a phase 2 randomized control trial
-
A phase 3 multicenter, prospective, open-label efficacy and safety study of immune globulin (human) 10% caprylate/chromatography purified in patients with myasthenia gravis exacerbations